I hate to agree with you, but it does appear that time to approval is some way off. As HALO said, 202 data is blinded until the 4th quarter. And we still have no visibility on the partner diagnostic for 303. People are getting antsy. That's all given. I, however, would contend that they are being very constructive on financing the ongoing trails. Yes, there should be some tought questions on the CC. Good. In the end, HALO offers a totally unique, proprietary treatment for numerous cancer types, however. Potentially. So far the evidence is that it works in vivo. They have a large molecule delivery platform which is highly effective. It's the big picture, dude. This is a good price and I'm buying.
No products. Just the much hyped tier one customers. Stock won't go up until the tech is incorporated into a product that people really want to buy. Not there yet.
Yes, another good report. It was a stressful couple of months since the last report took a lot of the mojo out of the stock. I think we're back on track.
He doesn't move the price of this stock anymore than you do. He does highlight some interesting company relevant information. That's nice. Not much else on this board, really.
Much trepidation going into the report. Where have the cheerleaders gone? Expectations are so low, maybe they will surprise us, for a change. Nah! Hope they finally have something concrete to say about the companion diagnostic, at least. I'm looking forward to the rationale for the debt deal to be addressed by the analyst community. Timeline for Humira would be great, but I guess that's up to ABT.
Hard to tell. Clearly shorts have been feasting. They will be covering. Too soon to say if we'll see sustained accumulation. This market is a motha.
Announcement that the diagnostic is ready removes a big overhang, IMO.
Still, I don't think we really get out of the mud until there is a solid new product offering form either of the platforms. Hopefully Humira.
Last earning, which were also impressive came, out on an awful market today. A little bit more fortunate today. Is the market finally ready to notice? 28K shares today. Not yet!
Well, they didn't sell much. Revenues were pathetic. Battery ready later this year. Whisper chip is the only thing I can see to get excited about. Hopefully.
Tape is obviously in a long decline, but won't disappear. Eventually it will reach a point where comps will turn up, if they can keep up the momentum of Storenext. Outstanding debt may be a problem. But under $1, this is a worthy speculation, IMO.